Text Size
657 studies found for:    "Venous Thrombosis"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
2 Recruiting Optimal Duration of Anticoagulation in Deep Venous Thrombosis
Conditions: Deep Venous Thrombosis of the Lower Extremities;   Symptomatic Recurrent Venous Thromboembolism
Intervention: Drug: Sodium warfarin
3 Active, not recruiting Aspirin for the Prevention of Recurrent Venous Thromboembolism
Conditions: Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolism;   Atherosclerosis
Intervention: Drug: aspirin
4 Active, not recruiting Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism;   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
5 Recruiting Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
6 Completed Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto,BAY59-7939)
7 Completed
Has Results 		Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Device: DVT-3000;   Device: SCD Express
8 Recruiting PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients
Conditions: Hemorrhagic Stroke;   Venous Thromboembolism;   Deep Venous Thrombosis
Interventions: Drug: Enoxaparin;   Other: Graduated compression stockings and/or intermittent pneumatic compression and/or early mobilization
9 Completed Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer
Conditions: Thrombosis;   Deep Venous Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism;   Pancreas Cancer;   Esophagus Cancer;   Gastric Cancer
Intervention:
10 Enrolling by invitation Obstructive Sleep Apnea and Venous Thromboembolism
Conditions: Obstructive Sleep Apnea;   Venous Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Intervention:
11 Recruiting A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate;   Drug: enoxaparin/unfractionated heparin;   Drug: warfarin
12 Not yet recruiting Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
13 Completed Odiparcil For The Prevention Of Venous Thromboembolism
Conditions: Fibrillation, Atrial;   Deep Vein Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Interventions: Drug: Odiparcil;   Drug: Warfarin;   Drug: Coumadin
14 Active, not recruiting A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Conditions: Deep Vein Thrombosis;   Coronary Artery Bypass Surgery;   Venous Thromboembolism
Interventions: Drug: Fondaparinux;   Other: Placebo
15 Recruiting Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
16 Recruiting Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
17 Completed Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
Conditions: Venous Thrombosis;   Surgery;   Deep Vein Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism;   Abdominal Surgery
Interventions: Drug: Fondaparinux Sodium;   Other: Placebo
18 Recruiting Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)
Conditions: Recurrent Venous Thromboembolism;   Idiopathic Deep Vein Thrombosis
Interventions: Drug: warfarin;   Drug: placebo of warfarin
19 Completed Epidemiology of Venous Thromboembolism
Conditions: Venous Thromboembolism;   Pulmonary Embolism;   Cancer;   Deep Vein Thrombosis;   COPD
Intervention:
20 Completed A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Anticoagulants;   Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Enoxaparin Sodium;   Embolism and Thrombosis;   Deep Vein Thrombosis;   DU-176b;   Edoxaban;   Factor Xa;   Oral;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176V 15 mg tablets oral, once daily for 2 weeks;   Drug: DU-176b 30 mg tablets, oral once daily for 2 weeks;   Drug: Enoxaparin sodium 20 mg (=2000IU) / 0.2ml twice daily, subcutaneous
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years